Cardiogenic Shock News and Research

RSS

Cardiogenic shock is based upon an inadequate circulation of blood due to primary failure of the ventricles of the heart to function effectively.

Novel biomarkers required to triage and monitor severely ill COVID-19 patients

Diagnostics company SphingoTec GmbH ("sphingotec") announced today the results of a working group meeting of clinical experts that discussed the utility of sphingotec's diagnostic solutions for acute and critical care in supporting the triage, diagnosis, and management of severely ill COVID-19 patients.

18 Jun 2020

Immunotherapy, steroids restore heart function in children with COVID-related multi-system inflammatory syndrome

Treatment with antibodies purified from donated blood - immune globulin therapy - and steroids restored heart function in the majority of children with COVID-related multi-system inflammatory syndrome, according to new research published yesterday in Circulation, the flagship journal of the American Heart Association.

19 May 2020

Steroids and immunotherapy improve outcomes in children with COVID-related multi-system inflammatory syndrome

19 May 2020

A novel approach to predict heart damage in COVID-19 patients

Johns Hopkins researchers recently received a $195,000 Rapid Response Research grant from the National Science Foundation to, using machine learning, identify which COVID-19 patients are at risk of adverse cardiac events such as heart failure, sustained abnormal heartbeats, heart attacks, cardiogenic shock and death.

18 May 2020

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.

15 May 2020

China with the world: COVID-19 experts dialogues - the 2nd talk transcript

Q: Starting from the patient admission to the hospital, what is your rule for ventilation? Do you start from HFNC, CPAP, NIV or go directly to intubation and invasive ventilation when the conventional oxygen therapy fails?

From Mindray 15 Apr 2020

New scientific statement outlines the resources needed to treat fulminant myocarditis

The resources needed to treat fulminant myocarditis - severe, inflammation of the heart that develops rapidly - are outlined in a new Scientific Statement from the American Heart Association on how best to reduce fatalities from this rare condition.

6 Jan 2020

Heart pumps linked to complications in some patients who underwent stent procedures

In critically ill patients who require a heart pump to support blood circulation as part of stent procedures, specific heart pumps have been associated with serious complications, according to a new study led by cardiologists at Washington University School of Medicine in St. Louis.

18 Nov 2019

Risk factors of malignant arrhythmias found in patients treated with therapeutic hyperthermia after cardiac arrest

Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.

5 Nov 2019

SCAI's new shock classification scheme used to analyze patients in cardiac intensive care unit

A new shock classification scheme released by the Society for Cardiovascular Angiography and Interventions and endorsed by the American College of Cardiology, American Heart Association, the Society of Critical Care Medicine and the Society of Thoracic Surgeons was recently applied in a retrospective study analyzing patients in the cardiac intensive care unit at the Mayo Clinic.

20 Sep 2019

$Team approach to care increases likelihood of surviving refractory cardiogenic shock$

Team approach to care increases likelihood of surviving refractory cardiogenic shock

When multidisciplinary health care teams were engaged in caring for patients suffering from refractory cardiogenic shock, a severe condition that can occur after a heart attack, the likelihood of survival increased significantly, by approximately 50 percent.

11 Jul 2019

New tool will help implement more precise treatments for patients with cardiogenic shock

A joint research effort by the Hospital and the Instituto de Investigación Germans Trias i Pujol is characterizing and studying a new cohort of cardiogenic shock patients to predict the risk of having this heart attack-derived complication which, while infrequent, sometimes presents a fatal outcome.

17 Jun 2019

Combining new tool with existing methods renders precise and patient-specific decision-making possible

17 Jun 2019

Study sheds light on the optimal timing of coronary angiography in NSTEMI patients

In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Research explores role of autopsy in cardiovascular medicine

Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.

18 Jun 2018

Study shows positive outcomes of culprit-only approach compared to multivessel intervention

A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used for patients with multivessel disease (MVD) and acute myocardial infarction (AMI) with cardiogenic shock (CS).

28 Apr 2018

Debate sessions at Acute Cardiovascular Care 2018 to focus on treatment for heart attack patients

The optimal treatment for heart attack patients will be debated at Acute Cardiovascular Care 2018. The annual congress of the Acute Cardiovascular Care Association, a registered branch of the European Society of Cardiology, will be held 3 to 5 March at the MiCo Milano Congressi in Milan, Italy.

5 Feb 2018

Researchers successfully treat cardiogenic shock using percutaneous auxiliary artificial heart

The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use of Impella, a percutaneous auxiliary artificial heart, for the first time in Japan.

31 Oct 2017

Cancer patients less likely to receive evidence-based treatments for heart attack

Treatment of heart attack patients depends on their history of cancer, according to research published today in European Heart Journal: Acute Cardiovascular Care.

20 Sep 2017

Getinge announces next edition of ICU Experience for improving patient care

Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.

18 Sep 2017